AjaySheshadriMDMSCI
Pulmonology • Houston, TXAsthma & COPD, Infectious Disease, Pleural Disease, Thoracic Oncology
Associate Professor of Pulmonary Medicine
Dr. Sheshadri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-563-1987
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Pulmonary Disease and Critical Care Medicine, 2010 - 2013
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2007 - 2010
University of Texas Southwestern Medical SchoolClass of 2007
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2026
TN State Medical License 2023 - 2026
WA State Medical License 2023 - 2026
AL State Medical License 2023 - 2025
GA State Medical License 2023 - 2025
LA State Medical License 2023 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
- Join now to see all
Clinical Trials
- Efficacy and Safety of Beta-adrenoceptor Inverse Agonist, Nadolol, in Mild Asthma Start of enrollment: 2013 Mar 01
- Evaluating Clonogenic Epithelial Cell Populations in Patients With Bronchiolitis Obliterans Syndrome Start of enrollment: 2020 Aug 27
- Predictive Biomarkers for Pneumonitis After Chemoradiotherapy and Immunotherapy in Patients With Non-small Cell Lung Cancer Start of enrollment: 2021 Jan 21
Publications & Presentations
PubMed
- Pulmonary Immunocompromise in Stem Cell Transplantation and Cellular Therapy.Mahnoor Mir, Saadia Faiz, Anuradha G Bommakanti, Ajay Sheshadri
Clinics in Chest Medicine. 2025-03-01 - Coronavirus Disease-2019 in the Immunocompromised Host.Christopher D Bertini Jr, Fareed Khawaja, Ajay Sheshadri
Rheumatic Diseases Clinics of North America. 2025-02-01 - High peripheral T cell diversity is associated with lower risk of toxicity and superior response to dual immune checkpoint inhibitor therapy in patients with metastati...Mehmet Altan, Ruoxing Li, Ziyi Li, Runzhe Chen, Ajay Sheshadri
Journal for Immunotherapy of Cancer. 2024-12-25
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
